The Lustgarten Foundation is committed to transforming pancreatic cancer into a curable disease. Research is fundamental to changing patient outcomes. In fact, it is the only way to give patients a better chance for long-term survival.
Clinical Accelerator Initiative
Our groundbreaking research program ensures the most pioneering research advancements in early detection and new treatments are possible.
The Foundation invests in the world’s best earlier-detection research, giving patients and their families more hope than ever before.
Our research explores various approaches and technologies focused on learning about genetic and tumor markers and identifying mutations to customize treatment strategies.
Pancreatic Cancer Drug Development
We support the work to bring vital new treatments to patients by using existing drugs in different ways or creating unique compounds.